← FDA DRUG APPROVALS

FDA ANDA · ANDA212470

BUMETANIDE

Sponsor: JUBILANT GENERICS

APPLICATION
ANDA212470
TYPE
ANDA
ORIGINAL APPROVAL
2025-08-05
LATEST ACTION
2025-08-05
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

BUMETANIDEPrescription
BUMETANIDE 1MG · TABLET · ORAL
BUMETANIDEPrescription
BUMETANIDE 2MG · TABLET · ORAL
BUMETANIDEPrescription
BUMETANIDE 0.5MG · TABLET · ORAL

Approval history

2025-08-05UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →